The present invention is directed to compounds which contain substituted
napthyridines which inhibit the activity of Akt, a serine/threonine
protein kinase. The invention is further directed to chemotherapeutic
compositions containing the compounds of this invention and methods for
treating cancer comprising administration of the compounds of the
invention.